Biological Psychiatry 2000: Vol 48 Index

20 Pages·2000·7.4 MB·English

Author Index to Volume 48
Abi-Dargham A. See Kegeles LS Bartzokis G. See Altshuler LL Birmaher B. See De Bellis MD
Ablon JS. See Cohen LS Bastiirk M. See Turan MT Bish JA. See Gold JM
Abraham G. See David MM Batel P. See Gorwood P Blitchington TF. See Steffens DC
Adés J. See Gorwood P Battaglia M, Ogliari A, Maffei C, Marino Bliwise DL. See Woodward SH
Aggen SH. See Young EA C, Molteni M, Nobile M. Blumberg HP, Stern E, Martinez D,
Akamatsu T. See Shibui K Cautionary note: complex Ricketts S, de Asis J, White T,
Akil H. See Watson SJ (dys)function of the serotonin Epstein J, McBride PA, Eidelberg
Ali M. See Mangold D transporter, 334-corr D, Kocsis JH, Silbersweig DA.
Alila-Johansson A. See Lindblom N Baucom C. See Miguel-Hidalgo JJ Increased anterior cingulate and
Alpert NM. See Heckers S Bayles-Dazet W. See Winokur A caudate activity in bipolar mania,
Alpert NM. See Shin LM Beardslee WR. See Steingard RJ 1045
Altemus M. See Frank GK Bebchuk JM. See Moore GJ Boni C. See Gorwood P
Altshuler L. See Rush AJ Begleiter H. See Hada M Boring AM. See De Bellis MD
Altshuler LL, Bartzokis G, Grieder T, Beiser M. See Sponheim SR Bottos C. See Bellivier F
Curran J, Jimenez T, Leight K, Bellivier F, Sz6ke A, Henry C, Lacoste J, Bouffard SM. See Cohen LS
Wilkins J, Gerner R, Mintz J. An Bottos C, Nosten-Bertrand M, Bouhuys AL. See Flentge F
MRI study of temporal lobe Hardy P, Rouillon F, Launay J-M, Brannan SK. See Liotti M
structures in men with bipolar Laplanche J-L, Leboyer M. Possible Brannan SK. See Mayberg HS
disorder or schizophrenia, 147 association between serotonin Bravi D. See Sacchetti E
Ancoli-Israel S. See Bardwell WA transporter gene polymorphism and Brent DA. See Dahl RE
Andreasen NC. See Crespo-Facorro B violent suicidal behavior in mood Breslau N, Davis GC, Peterson EL,
Andreasen NC. See Sears LL disorders, 319 Schultz LR. A second look at
Angst J, Sellaro R. Historical perspectives Benazon NR. See Rosenberg DR comorbidity in victims of trauma:
and natural history of bipolar the posttraumatic siress disorder—
Benson BE. See Osuch EA
disorder, 445 major depression connection, 902
Benson ES. See Manoach DS
Arana GW. See George MS Brodkin K. See Pascualy M
Berga SL. See Moses EL
Arciniegas D. See Teale P Broft A. See Martinez D
Berrettini WH. Are schizophrenic and
Arndt S. See Strakowski SM Bromet EJ. See Neria Y
bipolar disorders related? A review
Arsenault NJ. See Woodward SH Brooke SM, Sapolsky RM. The effects of
of family and molecular studies,
Austin MC. See Glantz LA steroid hromones in HIV-related
531
Axelson DA. See Dahl RE neurotoxicity: a mini review, 881
Biederman J. See Faraone SV
Axelson DA. See De Bellis MD Brunner D. See Gross C
Biederman J, Faraone SV, Wozniak J,
Buchanan RW. See Gold JM
Monuteaux MC. Parsing the
Bailey JW. See Cohen LS Buppanharun W. See Chanpattana W
association between bipolar,
Bakshi VP, Kalin NH. Corticotropin- Butters MA. See Moses EL
conduct, and substance use
releasing hormone and animal Byrum CE. See Lai T-J
disorders: a familial risk analysis,
models of anxiety: Byrum CE. See Steffens DC
1037
gene—environment interactions,
Biederman J, Mick E, Faraone SV,
1175 Caldji C, Diorio J, Meaney MJ.
Spencer T, Wilens TE, Wozniak
Baldessarini RJ. See Tohen M Variations in maternal care in
Ballenger JC. See George MS J. Pediatric mania: a developmental infancy regulate the development of
Bardwell WA, Moore P, Ancoli-Israel S, subtype of bipolar disorder?, 458 stress reactivity, 1164
Bienvenu OJ, Samuels JF, Riddle MA, Campbell IG. See Tan X
Dimsdale JE. Does obstructive
Hoehn-Saric R, Liang K-Y, Cuilen Candemir Z. See Turan MT
sleep apnea confound sleep
BAM, Grados MA, Nestadt G. The Carlsson A. See Kegeles LS
architecture findings in subjects
relationship of obsessive— Casey BJ. See De Bellis MD
with depressive symptoms?, 1001
Barrio JR. See MacLaren DC compulsive disorder to possible Chakrabhand MLS. See Chanpattana W
spectrum disorders: results from a Chanpattana W, Chakrabhand MLS,
family study, 287 Buppanharun W, Sackeim HA.
Abbreviations:
Bilker W. See Kohler CG Effects of stimulus intensity on the
ed, editorial
corr, correspondence Birmaher B. See Dahl RE efficacy of bilateral ECT in
© 2000 Society of Biological Psychiatry 0006-3223/00/$20.00
PII $0006-3223(00)01 103-3
Author Index to Volume 48 BIOL PSYCHIATRY 1231
2000;48: 1230-1237
schizophrenia: a preliminary study, Dorn L, Perel J, Kaufman J, Brent Ehlert I. See Kraemer S
222 DA, Axelson DA. Ryan ND. Low Eidelberg D. See Blumberg HP
Charney DS. See Fujita M growth hormone response to growth Emamghoreishi M, Li PP, Schlichter L,
Charney DS. See Kaufman J hormone—releasing hormone in Parikh SV, Cooke R, Warsh JJ.
Charney DS. Bipolar disorder: can studies child depression, 981 Associated disturbances in calcium
of natural history help us define Danker-Hopfe H. See Kraemer S homeostasis and G
clinically and neurobiologically David MM, Owen JA, Abraham G, Delva protein—mediated cAMP signaling
relevant subtypes?, 427-ed NJ, Southmayd SE, Wooltorton E, in bipolar I disorder, 665
Chen B, Wang JF, Young LT. Chronic Lawson JS. Thyroid function and Epstein J. See Blumberg HP
valproate treatment increases response to 48-hour sleep Esel E. See Turan MT
expression of endoplasmic deprivation in treatment-resistant Exton MS. See Meyer G
reticulum stress proteins in the rat depressed patients, 323
cerebral cortex and hippocampus, Davis GC. See Breslau N Faedda GL. See Tohen M
658 Davis KL. See Sokolov BP Faraone SV. See Biederman J
Chen G. See Manji HK Dawson R. See Lavori PW Faraone SV. See Fucetola R
Chen G. See Moore GJ Dean B. See Crook JM Faraone SV. See Tsuang MT
Cherry SR. See MacLaren DC de Asis J. See Blumberg HP Faraone SV, Biederman J, Monuteaux
Christensen JD, Kaufman MJ, Frederick De Bellis MD, Casey BJ, Dahl RE, MC. Attention-deficit disorder and
BdeB, Rose SL, Moore CM, Lukas Birmaher B, Williamson DE, conduct disorder in girls: evidence
SE, Mendelson JH, Cohen BM, Thomas KM, Axelson DA, Frustaci for a familial subtype, 21
Renshaw PF. Proton magnetic K, Boring AM, Hall J, Ryan ND. A Faraone SV, Biederman J, Spencer T,
resonance spectroscopy of human pilot study of amygdala volumes in Wilens T, Seidman LJ, Mick E,
basal ganglia: response to cocaine pediatric generalized anxiety Doyle AE.
administration, 685 disorder, 51 Attention-deficit/hyperactivity
Clementz BA. See Sponheim SR Delahanty DL, Raimonde AJ, Spoonster disorder in adults: an overview, 9
Clopton P. See Parry BL E. Initial posttraumatic urinary Faraone SV, Seidman LJ, Kremen WS,
Cohen BM. See Christensen JD cortisol levels predict subsequent Toomey R, Pepple JR, Tsuang MT.
Cohen BM. See Stoll AL PTSD symptoms in motor vehicle Neuropsychologic functioning
Cohen BM. See Tohen M accident victims, 940 among the nonpsychotic relatives of
Cohen LS, Heller VL, Bailey JW, Grush DelBello MP. See Strakowski SM schizophrenic patients: the effect of
L, Ablon JS, Bouffard SM. Birth Delgado PL. See Moreno FA genetic loading, 120
outcomes following prenatal DeLisi LE. See Gharaibeh WS Faulk MW. See Moore GJ
exposure to fluoxetine, 996 DeLisi LE, Razi K, Stewart J, Relja M, Fava M. See Goldstein G
Comazzi M. See DeLisi LE Shields G, Smith AB, Wellman N, Feinberg I. See Tan X
Cooke R. See Emamghoreishi M Larach VW, Loftus J, Vita A, Fischman AJ. See Heckers S
Cooper TB. See Kegeles LS Comazzi M, Crow TJ. No evidence Fischman AJ. See Shin LM
Copolov DL. See Crook JM for a parent-of-origin effect Fisher A. See Goldstein G
Crespo-Facorro B, Kim J-J, Andreasen detected in the pattern of Fleck DE. See Strakowski SM
NC, O’Leary DS, Magnotta V. inheritance of schizophrenia, 706 Flentge F, van den Berg MD, Bouhuys
Regional frontal abnormalities in Delva NJ. See David MM AL, The HT. Increase of NK-T
schizophrenia: a quantitative gray Dickey CC. See Niznikiewicz MA cells in aged depressed patients not
matter volume and cortical surface Dilley G. See Miguel-Hidalgo JJ treated with antidepressive drugs,
size study, 110 Dilley G. See Piletz JE 1024
Crook JM, Tomaskovic-Crook E, Dimsdale JE. See Bardwell WA Fox PT. See Liotti M
Copolov DL, Dean B. Decreased Diorio J. See Caldji C Frank E, Swartz HA, Kupfer
muscarinic receptor binding in Dorn H. See Kraemer S DJ. Interpersonal and social rhythm
subjects with schizophrenia: a study Dorn L. See Dahl RE therapy: managing the chaos of
of the human hippocampal Dougherty DD. See Shin LM bipolar disorder, 593
formation, 381 Doyle AE. See Faraone SV Frank GK, Kaye WH, Altemus M,
Crow TJ. See DeLisi LE Drevets WC. See Moses EL Greeno CG. CSF oxytocin and
Cullen BAM. See Bienvenu OJ Drevets WC. Neuroimaging studies of vasopressin levels after recovery
Culler M. See Goldstein G mood disorders, 813 from bulimia nervosa and anorexia
Curran J. See Altshuler LL D’Sa C. See Duman RS nervosa, bulimic subtype, 315
Curran T. See Heckers S Duman RS, Malberg J, Nakagawa S, Frederick BdeB. See Christensen JD
D’Sa C. Neuronal plasticity and Freed WJ. See Vawter MP
Dahl RE. See De Bellis MD survival in mood disorders, 732 Frustaci K. See De Bellis MD
Dahl RE, Birmaher B, Williamson DE, Diindar M. See Turan MT Fucetola R, Seidman LJ, Kremen WS,
1232 BIOL PSYCHIATRY Author Index to Volume 48
2000;48: 1230-1237
Faraone SV, Goldstein JM, Tsuang major depression, 65 Hauger R. See Parry BL
MT. Age and neuropsychologic Goldstein JM. See Fucetola R Hayakawa T. See Shibui K
function in schizophrenia: a decline Gollub RL. See Manoach DS Hayes JB. See Winokur A
in executive abilities beyond that Goodman AB, Pardee AB. Meeting Heckers S, Curran T, Goff D, Rauch SL,
observed in healthy volunteers, 137 report: “Molecular Neurobiological Fischman AJ, Alpert NM, Schacter
Fujita M, Charney DS, Innis RB. Imaging Mechanisms in Schizophrenia: DL. Abnormalities in the thalamus
serotonergic neurotransmission in Seeking a Synthesis,” April 11-14, and prefrontal cortex during
depression: hippocampal 1999, 173 episodic object recognition in
pathophysiology may mirror global Gorwood P, Batel P, Adés J, Hamon M, schizophrenia, 651
brain alterations, 801 Boni C. Serotonin transporter gene Heller VL. See Cohen LS
polymorphisms, alcoholism, and Hen R. See Gross C
Gage FH. Structural plasticity: cause, suicidal behavior, 259 Heninger GR. See Moreno FA
result, or correlate of depression, Gould E, Tanapat P, Rydel T, Hastings Hennen J. See Steingard RJ
713-ed N. Regulation of hippocampal Hennen J. See Tohen M
Gambhir SS. See MacLaren DC neurogenesis in adulthood, 715 Henry C. See Bellivier F
Gary KA. See Winokur A Grados MA. See Bienvenu OJ Herbert J. See Michael A
Gebre-Medhin P. See Tohen M Green M. See Hua LV Herrmann WM. See Kraemer S
George EL. See Miklowitz DJ Greenberg DL. See Steffens DC Herschman HR. See MacLare DC
George MS. See Osuch EA Greenhouse JB. On clinical trials in Herscovitch P. See Osuch EA
George MS, Nahas Z, Molloy M, Speer psychiatry, 433-ed Herscovitch P. See Speer AM
AM, Oliver NC, Li X-B, Arana Greeno CG. See Frank GK Hill SY, Shen S, Lowers L, Locke J.
GW, Risch SC, Ballenger JC. A Greer PJ. See Moses EL Factors predicting the onset of
controlled trial of daily left Grieder T. See Altshuler LL adolescent drinking in families at
prefrontal cortex TMS for treating Griez E, van Beek N. Reactivity to a high risk for developing alcoholism,
depression, 962 35% CO, challenge in healthy first- 265
Gerner R. See Altshuler LL degree relatives of patients with Hirschmann S. See Peled A
Geva AB. See Peled A panic disorder, 1223-corr (response) Hobart MP. See Gold JM
Gharaibeh WS, Rohlf FJ, Slice DE, Gross C, Santarelli L, Brunner D, Zhuang Hoehn-Saric R. See Bienvenu OJ
DeLisi LE. A geometric X, Hen R. Altered fear circuits in Hostetter A, Ritchie JC, Stowe ZN.
morphometric assessment of change 5-HT,, receptor KO mice, 1157 Amniotic fluid and umbilical cord
in midline brain structural shape Grossberg S. The imbalanced brain: from blood concentrations of
following a first episode of normal behavior to schizophrenia, antidepressants in three women,
schizophrenia, 398 81 1032
Gilbert A. See Rosenberg DR Grupper D. See Maayan R Hua LV, Green M, Warsh JJ, Li PP.
Gilmore JH. See Jarskog LF Grush L. See Cohen LS Lithium regulation of aldolase A
Glantz LA, Austin MC, Lewis DA. Guarneri L. See Sacchetti E expression in the rat frontal cortex:
Normal cellular levels of Gur RC. See Kohler CG identification by differential
synaptophysin mRNA expression in Gur RE. See Kohler CG display, 58
the prefrontal cortex of subjects Hyman SE. Goals for research on bipolar
with schizophrenia, 389 Hada M, Porjesz B, Begleiter H, Polich J. disorder: the view from NIMH, 436
Glitz DA. See Moore GJ Auditory P3a assessment of male
Goff DC. See Heckers S alcoholics, 276 Iacono WG. See Sponheim SR
Goff DC. See Manoach DS Hagendoorn M. See Kohler CG Iannone VN. See Gold JM
Gold JM, Bish JA, Iannone VN, Hobart Halaris A. See Piletz JE Innis RB. See Fujita M
MP, Queern CA, Buchanan RW. Halbreich U. See Piletz JE Ishibashi K. See Shibui K
Effects of contextual processing on Hall J. See De Bellis MD
visual conditional associative Halpern E. See Manoach DS Jarskog LF, Gilmore JH, Selinger ES,
learning in schizophrenia, 406 Hamon M. See Gorwood P Lieberman JA. Cortical bcl-2
Goldsmith HH, Lemery KS. Linking Hanna GL. See Rosenberg DR protein expression and apoptotic
temperamental fearfulness and Hardy P. See Bellivier F regulation in schizophrenia, 641
anxiety symptoms: a Hare RD. See Kiehl KA Jauss M, Pantel J, Werle E, Schréder J.
behavior—genetic perspective, 1199 Haroutunian V. See Sokolov BP G-CSF plasma levels in clozapine-
Goldstein G, Fava M, Culler M, Fisher Harris JG. See Ross RG induced neutropenia, 1113
A, Rickels K, Lydiard RB, Hasanat K. See Moore GJ Javeed S. See Parry BL
Rosenbaum J. Elevated plasma Hastings N. See Gould E Jenaway A. See Michael A
thymopoietin associated with Haténen T. See Lindblom N Jentsch JD, Roth RH, Taylor JR. Object
therapeutic nonresponsiveness in Hauffa BP. See Meyer G retrieval/detour deficits in monkeys
Author Index to Volume 48 BIOL PSYCHIATRY 1233
2000;48: 1230-1237
produced by prior subchronic Kmiec JA. See Sweeney JA Lewis L. A consumer perspective
phencyclidine administration: Knight DL. See Owens MJ concerning the diagnosis and
evidence for cognitive impulsivity, Koch S. See Moore GJ treatment of bipolar disorder, 442
415 Kocsis JH. See Blumberg HP Li PP. See Emamghoreishi M
Jerabek PA. See Liotti M Kohler CG, Bilker W, Hagendoorn M, Li PP. See Hua LV
Jerabek PA. See Mayberg HS Gur RE, Gur RC. Emotion Li X-B. See George MS
Jimenez T. See Altshuler LL recognition deficit in schizophrenia: Liang K-Y. See Bienvenu OJ
Jolkovsky L. See Moore GJ association with symptomatology Liddle PF. See Kiehl KA
and cognition, 127 Lieberman JA. See Jarskog LF
Kalbag A. See Miklowitz DJ Kraemer S, Danker-Hopfe H, Dorn H, Lindblom N, Haténen T, Laakso M-L,
Kalin NH. See Bakshi VP Schmidt A, Ehlert I, Herrmann Alila-Johansson A. Laipio M-L,
Kalro BN. See Moses EL WM. Time-of-day variations of Turpeinen U. Bright light exposure
Kamei Y. See Shibui K indicators of attention: performance, of a large skin area does not affect
Kaoud MA. See Maayan R physiologic parameters, and self- melatonin or bilirubin levels in
Katic A. See Steingard RJ assessment of sleepiness, 1069 humans, 1098
Kaufman J. See Dahl RE Kremen WS. See Faraone SV Liotti M. See Pliszka SR
Kaufman J, Plotsky PM, Nemeroff CB, Kremen WS. See Fucetola R Liotti M, Mayberg HS, Brannan SK,
Charney DS. Effects of early Krishnan KRR. See Steffens DC McGinnis S, Jerabek P, Fox PT.
adverse experiences on brain Kudo Y. See Shibui K Differential limbic—cortical
structure and function: clinical Kupfer DJ. See Frank E correlates of sadness and anxiety in
implications, 778 Kupfer DJ. See Sweeney JA healthy subjects: implications for
Kaufman MJ. See Christensen JD Kupfer DJ. Models of bipolar disease and affective disorders, 30
Kaye WH. See Frank GK their clinical implications, 428-ed Liu X. See Shibui K
Keck ME. See Miiller MB Locke J. See Hill SY
Keck PE Jr. See McElroy SL Laakso M-L. See Lindblom N Loftus J. See DeLisi LE
Keck PE Jr. See Rush AJ Lacoste J. See Bellivier F Lopresti B. See Moses EL
Keck PE Jr. Treatment advances in Lai T-J, Payne ME, Byrum CE, Steffens Loucks TL. See Moses EL
biplolar disorder—making up for DC, Kirshman KRK. Reduction of Lowers L. See Hill SY
lost time, 430-ed orbital frontal cortex volume in Lu Y. See Rollema H
Kegeles LS, Abi-Dargham A, Zea-Ponce geriatric depression, 971 Lukas SE. See Christensen JD
Y, Rodenhiser-Hill J, Mann JJ, Van Laipio M-L. See Lindblom N Lupien SJ. Stress and schizophrenia: the
Heertum RL, Cooper TB, Carlsson Landgraf R. See Miiller MB importance of cognition, 1119-ed
A, Laruelle M. Modulation of Lane A. See Quinn J Lupien SJ, King S, Meaney MJ, McEwen
amphetamine-induced striatal Laplanche J-L. See Bellivier F BS. Child’s stress hormone levels
dopamine release by ketamine in Larach VW. See DeLisi LE correlate with mother’s
humans: implications for Laruelle M. See Kegeles LS socioeconomic status and
schizophrenia, 627 Laruelle M. See Martinez D depressive state, 976
Kendler KS. See Young EA Lasko M. See Shin LM Lydiard RB. See Goldstein G
Keshavan MS. See Stanley JA Laughlin GA. See Parry BL
Keshavan MS, Stanley JA, Pettegrew JW. Launay J-M. See Bellivier F Maayan R, Yagorowski Y, Grupper D,
Magnetic resonance spectroscopy in Launay J-M. See Leboyer M Weiss M, Shtaif B, Kaoud MA,
schizophrenia: methodological Lavori PW, Dawson R, Rush AJ. Flexible Weizman A. Basal plasma
issues and findings—part II, 369 treatment strategies in chronic dehydroepiandrosterone sulfate
Ketter TA. See Osuch EA disease: clinical and research level: a possible predictor for
Kiehl KA, Smith AM, Hare RD, Liddle implications, 605 response to electroconvulsive
PF. An event-related potential Lawson JS. See David MM therapy in depressed psychotic
investigation of response inhibition Leboyer M. See Bellivier F inpatients, 693
in schizophrenia and psychopathy, Leboyer M, Launay J-M. Cautionary MacDonald MM. See Winokur A
210 note: complex (dys)function of the MacFall JR. See Steffens DC
Kim J-J. See Crespo-Facorro B serotonin transporter, 335-corr Macklin ML. See Shin LM
Kim K. See Shibui K (response) MacLaren DC, Toyokuni T, Cherry SR,
Kimbrell TA. See Osuch EA Leight K. See Altshuler LL Barrio JR, Phelps ME, Herschman
Kimbrell TA. See Speer AM Lemery KS. See Goldsmith HH HR, Gambhir SS. PET imaging of
King S. See Lupien SJ Lenox RH. See Manji HK transgene expression, 337
Kinsella A. See Quinn J Leondires MP. See Moses EL Maffei C. See Battaglia M
Kirshman KRK. See Lai T-J Lewine RJ. See Walder DJ Magnotta V. See Crespo-Facorro B
Kleinman JE. See Vawter MP Lewis DA. See Glantz LA Mahurin RK. See Mayberg HS
1234 BIOL PSYCHIATRY Author Index to Volume 48
2000;48: 1230-1237
Malberg J. See Duman RS Meaney MJ. See Lupien SJ CA, Delgado PL. Tryptophan
Mangold D, McCaul ME, Ali M, Wand Meltzer HY. See Miguel-Hidalgo JJ depletion and risk of depression
GS. Plasma adrenocorticotropin Mendelson JH. See Christensen JD relapse: a prospective study of
responses to opioid blockade with Meng F. See Watson SJ tryptophan depletion as a potential
naloxone: generating a Meyer G, Hauffa BP, Schedlowski M, predictor of depressive episodes,
dose-response curve in a single Pawlak C, Stadler MA, Exton MS. 327
session, 310 Casino gambling increases heart Moses EL, Drevets WC, Smith G, Mathis
Manji HK. See Moore GJ rate and salivary cortisol in regular CA, Kalro BN, Butters MA,
Manji HK, Lenox RH. Signaling: cellular gamblers, 948 Leondires MP, Greer PJ, Lopresti
insights into the pathophysiology of Michael A, Jenaway A, Paykel ES, B, Loucks TL, Berga SL. Effects of
bipolar disorder, 518 Herbert J. Altered salivary estradiol and progesterone
Manji HK, Moore GJ, Chen G. Clinical dehydroepiandrosterone levels in administration on human serotonin
and preclinical evidence for the major depression in adults, 989 2A receptor binding: a PET study,
neurotrophic effects of mood Mick E. See Biederman J 854
stabilizers: implications for the Mick E. See Faraone SV Miiller MB, Landgraf R, Keck ME.
pathophysiology and treatment of Miguel-Hidalgo JJ, Baucom C, Dilley G, Vasopressin, major depression, and
manic—depressive illness, 740 Overholser JC, Meltzer HY, hypothalamic—pituitary—adrenocortical
Mann JJ. See Kegeles LS Stockmeier CA, Rajkowska G. desensitization, 330
Manoach DS, Gollub RL, Benson ES, Glial fibrillary acidic protein Murray C. See Woodward SH
Searl MM, Goff DC, Halpern E, immunoreactivity in the prefrontal
Saper CB, Rauch SL. Schizophrenic cortex distinguishes younger from Nahas Z. See George MS
subjects show aberrant [MRI older adults in major depressive Nakagawa S. See Duman RS
activation of dorsolateral prefrontal disorder, 861 Nemeroff CB. See Kaufman J
cortex and basal ganglia during Miklowitz DJ, Simoneau TL, George EL, Nemeroff CB. See Owens MJ
working memory performance, 99 Richards JA, Kalbag A, Sachs- Neria Y, Bromet EJ. Comorbidity of
Marino C. See Battaglia M Ericsson N, Suddath R. Family- PTSD and depression: linked or
Martinez D. See Blumberg HP focused treatment of bipolar separate incidence, 878-ed
Martinez D, Broft A, Laruelle M. disorder: 1-year effects of a Nestadt G. See Bienvenu OJ
Pindolol augmentation of psychoeducational program in Niznikiewicz MA, Voglmaier MM,
antidepressant treatment: recent conjunction with pharmacotherapy, Shenton ME, Dickey CC, Seidman
contributions from brain imaging 582 LJ, Teh E, Van Rhoads R,
studies, 844 Mintz J. See Altshuler LL McCarley RW. Lateralized P3
Mathis CA. See Moses EL Modai I. See Peled A deficit in schizotypal personality
Mayberg HS. See Liotti M Moldin SO. Neurobiology of anxiety and disorder, 702
Mayberg HS, Brannan SK, Tekell JL, fear: challenges for genomic Nobile M. See Battaglia M
Silva JA, Mahurin RK, McGinnis science of the new millennium, Nolen WA. See Rush AJ
S. Jerabek PA. Regional metabolic 1144 Nosten-Bertrand M. See Bellivier F
effects of fluoxetine in major Molloy M. See George MS
depression: serial changes and Molteni M. See Battaglia M Ogliari A. See Battaglia M
relationship to clinical response, Monuteaux MC. See Biederman J Ohta K. See Shibui K
830 Monuteaux MC. See Faraone SV Okawa M. See Shibui K
McBride PA. See Blumberg HP Moore CM. See Christensen JD O’Leary DS. See Crespo-Facorro B
McCarley RW. See Niznikiewicz MA Moore CM. See Steingard RJ O’Leary DS. See Sears LL
McCaul ME. See Mangold D Moore GJ. See Manji HK Olincy A. See Ross RG
McElroy SL. See Rush AJ Moore GJ. See Rosenberg DR Oliver NC. See George MS
McElroy SL, Keck PE Jr. Pharmacologic Moore GJ, Bebchuk JM, Hasanat K, Ordway G. See Piletz JE
agents for the treatment of acute Chen G, Seraji-Bozorgzad N, Wilds Orr SP. See Shin LM
bipolar mania, 539 IB, Faulk MW, Koch S, Glitz DA, Osuch EA, Ketter TA, Kimbrell TA,
McEwen BS. See Lupien SJ Jolkovsky L, Manji HK. Lithium George MS, Benson BE, Willis
McEwen BS. Effects of adverse increases N-acetyl-aspartate in the MW, Herscovitch P, Post RM.
experiences for brain structure and human brain: in vivo evidence in Regional cerebral metabolism
function, 721 support of bcl-2’s neurotrophic associated with anxiety symptoms
McGahuey CA. See Moreno FA effects?, | in affective disorder patients, 1020
McGinnis S. See Liotti M Moore JC. See Steingard RJ Overholser JC. See Miguel-Hidalgo JJ
McGinnis S. See Mayberg HS Moore P. See Bardwell WA Owen JA. See David MM
McQuoid DR. See Steffens DC Moran M. See Quinn J Owens MJ, Nemeroff CB, Knight DL.
Meaney MJ. See Caldji C Moreno FA, Heninger GR, McGahuey Paroxetine binding to the rat
Author Index to Volume 48 BIOL PSYCHIATRY 1235
2000;48: 1230-1237
norepinephrine transporter in vivo, Plotsky PM. See Kaufman J and after cognitive behavioral
954-corr (response) Ozkul Y. See Polich J. See Hada M therapy, 294
Turan MT Porjesz B. See Hada M Rosenberg DR, Hanna GL. Genetic and
Post RM. See Osuch EA imaging strategies in obsessive—
Palagini L. See Tan X Post RM. See Rush AJ compulsive disorder: potential
Pantel J. See Jauss M Post RM. See Speer AM implications for treatment
Pardee AB. See Goodman AG Prescott CA. See Young EA development, 1210
Parikh SV. See Emamghoreishi M Ross RG, Olincy A, Harris JG, Sullivan
Parry BL, Javeed S, Laughlin GA, Queern CA. See Gold JM B, Radant A. Smooth pursuit eye
Hauger R, Clopton P. Cortisol Quinn J, Moran M, Lane A, Kinsella A, movements in schizophrenia and
circadian rhythms during the Waddington JL. Long-term adaptive attentional dysfunction: adults with
menstrual cycle and with sleep life functioning in relation to schizophrenia, ADHD, and a
deprivation in premenstrual initiation of treatment with normal comparison group, 197
dysphoric disorder and normal antipsychotics over the lifetime Roth RH. See Jentsch JD
control subjects, 920 trajectory of schizophrenia, 163 Rouillon F. See Bellivier F
Pascualy M, Petrie EC, Brodkin K, Rubin RT. Paroxetine binding to the rat
Peskind ER, Wilkinson CW, Radant A. See Ross RG norepinephrine transporter in vivo,
Raskind MA. Hypothalamic Raimonde AJ. See Delahanty DL 954-corr
pituitary adrenocortical and Rajkowska G. See Miguel-Hidalgo JJ Rush AJ. See Lavori PW
sympathetic nervous system Rajkowska G. Postmortem studies in Rush AJ, Post RM, Nolen WA, Keck PE
responses to the cold pressor test in mood disorders indicate altered Jr, Suppes T, Altshuler L, McElroy
Alzheimer’s disease, 247 numbers of neurons and glial cells, SL. Methodological issues in
Pawlak C. See Meyer G 766 developing new acute treatments for
Paykel ES. See Michael A Raskind MA. See Pascualy M patients with bipolar illness, 615
Payne ME. See Lai T-J Rauch SL. See Heckers S Ryan ND. See Dahl RE
Payne ME. See Steffens DC Rauch SL. See Manoach DS Ryan ND. See De Bellis MD
Peled A, Ritsner M, Hirschmann S, Geva Rauch SL. See Shin LM Rydel T. See Gould E
AB, Modai I. Touch feel illusion in Razi K. See DeLisi LE
schizophrenic patients, 1105 Reis D. See Piletz JE Sacchetti E, Guarneri L, Bravi D. H,
Pepple JR. See Faraone SV Reite M. See Teale P antagonist nizatidine may control
Perel J. See Dahl RE Relja M. See DeLisi LE olanzapine-associated weight gain
Peskind ER. See Pascualy M Renshaw PF. See Christensen JD in schizophrenic patients, 167
Peterson EL. See Breslau N Renshaw PF. See Steingard RJ Sachs-Ericsson N. See Miklowitz DJ
Petrie EC. See Pascualy M Renshaw PF. See Stoll AL Sachs GS. See Thase ME
Pettegrew JW. See Keshavan MS Repella J. See Speer AM Sachs GS, Thase ME. Bipolar disorder
Pettegrew JW. See Stanley JA Richards JA. See Miklowitz DJ therapeutics: maintenance treatment,
Phelps ME. See MacLaren DC Rickels K. See Goldstein G 573
Piletz JE, Halbreich U. Imidazoline and Ricketts S. See Blumberg HP Sackeim HA. See Chanpattana W
a,,-adrenoceptor binding sites in Riddle MA. See Bienvenu OJ Sackeim HA. Repetitive transcranial
postmenopausal women before and Risch SC. See George MS magnetic stimulation: what are the
after estrogen replacement therapy, Ritchie JC. See Hostetter A next steps?, 959-ed
932 Ritsner M. See Peled A Samuels JF. See Bienvenu OJ
Piletz JE, Zhu H, Ordway G, Stockmeier Rodenhiser-Hill J. See Kegeles LS Sanberg PR. See Shytle RD
C, Dilley G, Reis D, Halaris A. Rohlf FJ. See Gharaibeh WS Santarelli L. See Gross C
Imidazoline receptor proteins are Rojas DC. See Teale P Saper CB. See Manoach DS
decreased in the hippocampus of Rollema H, Lu Y, Schmidt AW, Sprouse Sapolsky RM. See Brooke SM
individuals with major depression, JS, Zorn SH. 5-HT,, receptor Sapolsky RM. The possibility of
910 activation contributes to neurotoxicity in the hippocampus in
Pitman RK. See Shin LM ziprasidone-induced dopamine major depression: a primer on
Pliszka SR, Liotti M, Woldorff MG. release in the rat prefrontal cortex, neuron death, 755
Inhibitory control in children with 229 Sateia MJ. See Winokur A
attention-deficit/hyperactivity Rose SL. Sec Christensen JD Schacter DL. See Heckers S
disorder: event-related potentials Rosenbaum J. See Goldstein G Schedlowski M. See Meyer G
identify the processing component Rosenberg DR, Benazon NR, Gilbert A, Schlichter L. See Emamghoreishi M
and timing of an impaired right- Sullivan A, Moore GJ. Thalamic Schmidt A. See Kraemer S
frontal response-inhibition volume in pediatric obsessive— Schmidt AW. See Rollema H
mechanism, 238 compulsive disorder patients before Schroder J. See Jauss M
1236 BIOL PSYCHIATRY Author Index to Volume 48
2000;48: 1230-1237
Schultz LR. See Breslau N Southmayd SE. See David MM Strakowski SM. See Tohen M
Searl MM. See Manoach DS Speer AM. See George MS Strakowski SM, DelBello MP, Fleck DE,
Sears LL, Andreasen NC, O’Leary DS. Speer AM, Kimbrell TA, Wassermann Arndt S. The impact of substance
Cerebellar functional abnormalities EM, Repella J, Willis MW, abuse on the course of bipolar
in schizophrenia are suggested by Herscovitch P, Post RM. Opposite disorder, 477
classical eyeblink conditioning, 204 effects of high and low frequency Suddath R. See Miklowitz DJ
Seidman LJ. See Faraone SV rTMS on regional brain activity in Sullivan A. See Rosenberg DR
Seidman LJ. See Fucetola R depressed patients, 1133 Sullivan B. See Ross RG
Seidman LJ. See Niznikiewicz MA Spencer T. See Biederman J Suppes T. See Rush AJ
Selinger ES. See Jarskog LF Spencer T. See Faraone SV Suppes T. See Tohen M
Sellaro S. See Angst J Sponheim SR, Clementz BA, Iacono WG, Swartz HA. See Frank E
Seraji-Bozorgzad N. See Moore GJ Beiser M. Clinical and biological Sweeney JA, Kmiec JA, Kupfer
Sheeder J. See Teale P concomitants of resting state EEG DJ. Neuropsychologic impairments
Sheline YI. 3D MRI studies of power abnormalities in in bipolar and unipolar mood
neuroanatomic changes in unipolar schizophrenia, 1088 disorders on the CANTAB
major depression: the role of stress Spoonster E. See Delahanty DL neurocognitive battery, 674
and medical comorbidity, 791 Sprouse JS. See Rollema H Szdke A. See Bellivier F
Shen S. See Hill SY Stadler MA. See Meyer G
Shenton ME. See Niznikiewicz MA Stahl SM. Placebo-controlled comparison Tan X, Campbell IG, Palagini L,
Shibui K, Uchiyama M, Okawa M, Kudo of the selective serotonin reuptake Feinberg I. High internight
Y, Kim K, Liu X, Kamei Y, inhibitors citalopram and sertraline, reliability of computer-measured
Hayakawa T, Akamatsu T, Ohta K, 894 NREM delta, sigma, and beta:
Ishibashi K. Diurnal fluctuation of Stanley JA. See Keshavan MS biological implications, 1010
sleep propensity and hormonal Stanley JA, Pettegrew JW, Keshavan MS. Tanapat P. See Gould E
secretion across the menstrual Magnetic resonance spectroscopy in Taylor JR. See Jentsch JD
cycle, 1062 schizophrenia: methodological Tcherepanov AA. See Sokolov BP
Shields G. See DeLisi LE issues and findings—part I, 357 Teale P, Reite M, Rojas DC, Sheeder J,
Shin LM, Dougherty DD, Orr SP, Pitman Steffens DC. See Lai T-J Arciniegas D. Fine structure of the
RK, Lasko M, Macklin ML, Alpert Steffens DC, Byrum CE, McQuoid DR, auditory M100 in schizophrenia and
NM, Fischman AJ, Rauch SL. Greenberg DL, Payne ME, schizoaffective disorder, 1109
Activation of anterior paralimbic Blitchington TF, MacFall JR, Teh E. See Niznikiewicz MA
structures during guilt-related Krishnan KRR. Hippocampal Tekell JL. See Mayberg HS
script-driven imagery, 43 volume in geriatric depression, 301 Thase ME. See Sachs GS
Shtaif B. See Maayan R Stein MB. Reactivity to a 35% CO, Thase ME, Sachs GS. Bipolar depression:
Shytle RD, Silver AA, Sanberg PR. challenge in healthy first-degree pharmacotherapy and related
Comorbid bipolar disorder in relatives of patients with panic therapeutic strategies, 558
Tourette’s syndrome responds to disorder, 1223-corr The HT. See Flentge F
the nicotinic receptor antagonist Steingard RJ, Yurgelun-Todd DA, Thomas KM. See De Bellis MD
mecamylamine (inversine), 1028 Hennen J, Moore JC, Moore CM, Thompson RC. See Watson SJ
Siever LJ. Antidepressant selection in the Vakili K, Young AD, Katic A, Tohen M, Strakowski SM, Zarate C Jr,
postgenomic era, 875-ed Beardslee WR, Renshaw PF. Hennen J, Stoll AL, Suppes T,
Silbersweig DA. See Blumberg HP Increased orbitofrontal cortex levels Faedda GL, Cohen BM, Gebre-
Silva JA. See Mayberg HS of choline in depressed adolescents Medhin P, Baldessarini RJ. The
Silver AA. See Shytle RD as detected by in vivo proton McLean-—Harvard First-Episode
Simoneau TL. See Miklowitz DJ magnetic resonance spectroscopy, Project: 6-month symptomatic and
Slice DE. See Gharaibeh WS 1053 functional outcome in affective and
Smith AB. See DeLisi LE Stern E. See Blumberg HP nonaffective psychosis, 467
Smith AM. See Kiehl KA Stewart J. See DeLisi LE Tomaskovic-Crook E. See Crook JM
Smith G. See Moses EL Stockmeier C. See Piletz JE Toomey R. See Faraone SV
Sofuoglu S. See Turan MT Stockmeier CA. See Miguel-Hidalgo JJ Toyokuni T. See MacLaren DC
Sokolov BP, Tcherepanov AA, Stoll AL. See Tohen M Tsuang MT. See Faraone SV
Haroutunian V, Davis KL. Levels Stoll AL, Renshaw PF, Yurgelun-Todd Tsuang MT. See Fucetola R
of mRNAs encoding synaptic DA, Cohen BM. Neuroimaging in Tsuang MT, Stone WS, Faraone SV.
vesicle and synaptic plasma bipolar disorder: what have we Towards the prevention of
membrane proteins in the temporal learned?, 505 schizophrenia, 349
cortex of elderly schizophrenic Stone WS. See Tsuang MT Turan MT, Esel E, Diindar M. Candemir
patients, 184 Stowe ZN. See Hostetter A Z, Bastiirk M, Sofuoglu S,
Author Index to Volume 48 BIOL PSYCHIATRY 1237
2000;48:1230—1237
Ozkul Y. Female-to-male Wand GS. See Mangold D sleep architecture in depressed
transsexual with 47,XXX Wang JF. See Chen B patients: a pilot study, 75
karyotype, 1116 Warsh JJ. See Emamghoreishi M Woldorff MG. See Pliszka SR
Turpeinen U. See Lindblom N Warsh JJ. See Hua LV Woodward SH, Arsenault NJ, Murray C,
Wassermann EM. See Speer AM Bliwise DL. Laboratory sleep
Uchiyama M. See Shibui K Watson SJ, Meng F, Thompson RC, Akil correlates of nightmare complaint in
Uhde TW. Genetics and brain function:
H. The “chip” as a specific genetic PTSD inpatients, 1081
implications for the treatment of
tool, 1147 Wooltorton E. See David MM
anxiety, 1142-ed
Weiss M. See Maayan R Wozniak J. See Biederman J
Weizman A. See Maayan R
Vakili K. See Steingard RJ
Wellman N. See DeLisi LE Yagorowski Y. See Maayan R
van Beek N. See Griez E
Werle E. See Jauss M Young AD. See Steingard RJ
van den Berg MD. See Flentge F
White T. See Blumberg HP Young EA, Aggen SH, Prescott CA,
Van Heertum RL. See Kegeles LS
Wilds IB. See Moore GJ Kendler KS. Similarity in saliva
Van Rhoads R. See Niznikiewicz MA
Wilens T. See Faraone SV cortisol measures in monozygotic
Vawter MP, Freed WJ, Kleinman JE.
Wilens TE. See Biederman J twins and the influence of past
Neuropathology of bipolar disorder,
Wilkins J. See Altshuler LL major depression, 70
486
Wilkinson CW. See Pascualy M Young LT. See Chen B
Vita A. See DeLisi LE
Williamson DE. See Dahl RE Yurgelun-Todd DA. See Steingard R
Vogimaier MM. See Niznikiewicz MA
Williamson DE. See De Bellis MD Yurgelun-Todd DA. See Stoll AL
Waddington JL. See Quinn J Willis MW. See Osuch EA
Walder DJ, Walker EF, Lewine RJ. Willis MW. See Speer AM Zarate C Jr. See Tohen M
Cognitive functioning, cortisol Winokur A, Sateia MJ, Hayes JB, Zea-Ponce Y. See Kegeles LS
release, and symptom severity in Bayles-Dazet W, MacDonald MM, Zhu H. See Piletz JE
patients with schizophrenia, 1121 Gary KA. Acute effects of Zhuang X. See Gross C
Walker EF. See Walder DJ mirtazapine on sleep continuity and Zorn SH. See Rollema H
Subject Index to Volume 48
N-Acetyl-aspartate levels factors in onset of adolescent alcohol use, 265
lithium affecting, 740 and pediatric mania, 458
ACTH. See also Corticotropin-releasing hormone serotonin transporter gene polymorphisms in, 259
plasma levels after naloxone, 310 Aldolase A
response to cold pressor test in Alzheimer’s disease, 247 brain levels affected by lithium, 58
Adaptive life functioning Alzheimer disease
in schizophrenia, 163 cold pressor test in, 247
Addiction Amniotic fluid
gambling affecting heart rate and salivary cortisol, 948 antidepressant concentrations in, 1032
serotonin transporter gene polymorphisms in, 259 cAMP
Adenylyl cyclase activity response element—binding protein
and signaling in bipolar disorder, 518 affecting cell survival, 732
calcium homeostasis affecting, 665 and expression of bcl-2 protein, 740
Adolescence signaling in bipolar disorder, 518
depression in, orbitofrontal cytosolic choline levels in, 1053 calcium homeostasis affecting, 665
factors in onset of alcohol use, 265 Amphetamine
Adrenal steroids and striatal dopamine release affected by ketamine, 627
and hippocampal neurogenesis, 801 Amygdala
and hippocampal neuron loss in depression, 755 MRI of men with bipolar disorder or schizophrenia, 147
and neurogenesis in adults, 715 neuroimaging in depression, 813
and neurotoxicity in HIV infection, 881 in pediatric anxiety, 51
and prefrontal cortex cell loss in depression, 766 responses in schizophrenia, 81
and structural plasticity of hippocampus, 721 Animal studies
a,,-Adrenoceptors corticotropin-releasing hormone in stress, 1175
binding sites affected by estrogen, 932 early stress affecting brain structure and function, 778
Affective disorders fear circuits in 5-HT, receptor knockout mice, 1157
neural correlates of sadness and anxiety, 30 lithium regulation of aldolase A expression, 58
object retrieval deficits from phencyclidine in monkeys,
and suicidal behavior related to serotonin transporter gene
415
polymorphism, 259, 319
paroxetine binding to norepinephrine transporter in rats,
and thyroid function in sleep deprivation, 323
954-corr
Age
PET imaging of transgene expression, 337
and brain morphology in schizophrenia, 398
stress reactivity affected by maternal care, 1164
and glial fibrillary acidic protein immunoreactivity in
valproate affecting endoplasmic reticulum stress proteins,
depression, 861
658
and neuropsychologic function in schizophrenia, 137
ziprasidone affecting dopamine release in prefrontal cortex,
Aged subjects
229
hippocampal volume in geriatric depression, 301
Anorexia nervosa
increased natural killer T cells in depression, 1024
CSF oxytocin and vasopressin levels in recovered subjects,
reduced orbitofrontal cortex volume in depression, 971
315
synaptic proteins in schizophrenia, 184
Antidepressants
AIDS-related dementia complex
and adenyl cyclase activity, 518
and neurotoxicity affected by steroid hormones, 881
affecting serotonin receptors, 801
Alcoholism
augmentation by pindolol, 844
association with bipolar and conduct disorders, 1037
in bipolar disorder, 558
auditory P3a in male alcoholics, 276
comparison of citalopram and sertraline, 894
and course of bipolar disorder, 477
concentrations in amniotic fluid, 1032
as maintenance therapy in bipolar disorder, 573
selection in postgenomic era, 875-ed
Abbreviations:
Antiepileptic drugs
ed, editorial
corr, correspondence in bipolar mania, 539
© 2000 Society of Biological Psychiatry 0006-3223/00/$20.00
PII S0006-3223(00)01 104-5
Subject Index to Volume 48 BIOL PSYCHIATRY 1239
2000:48:1238—1249
Antipsychotic drugs Bcl-2 protein
and adaptive life functioning in schizophrenia, 163 expression in schizophrenia, 641
in bipolar depression, 558 lithium affecting, 1
in bipolar mania, 539 mood stabilizers affecting, 740
as maintenance therapy in bipolar disorder, 573 Behavioral therapy
and molecular mechanisms in schizophrenia, 173 and thalamic volume in pediatric obsessive—compulsive
ziprasidone affecting dopamine release in prefrontal cortex, disorder, 294
229 Bilirubin
Anxiety serum levels affected by skin light exposure, 1098
Bipolar disorder
and altered fear circuits in knockout mice, 1158
genetics and brain function, implications for treatment of, antidepressants in, 558
1142-ed antimanic agents in, 539
in childhood association with conduct disorder and substance use, 1037
amygdala in, 51 calcium homeostasis and cAMP signaling in, 665
and pediatric mania, 458 cingulate and caudate activity in mania, 1045
course affected by substance abuse, 477
in mood disorders, cerebral metabolism in, 1020
development of acute phase treatments, 615
neural correlates of, 30
and evaluation of clinical trials in psychiatry, 433-ed
neurobiology of, 1145
family therapy in, 582
and nightmares in posttraumatic stress disorder, 1081
flexible treatment strategies, 605
and temperamental fearfulness, 1199
interpersonal and social rhythm therapy, 593
Apnea in sleep
lithium affecting N-acetyl-aspartate levels in brain, |
and sleep architecture in depression, 1001
lithium regulation of aldolase A expression, 58
Apoptosis
maintenance treatment, 573
and bcl-2 protein expression in schizophrenia, 641
models of, 426-ed
in mood disorders, 732
MRI of temporal lobe structures in men, 147
mood stabilizers affecting, 740
natural history of, 445
Arousal systems
neuroimaging in, 505
and gambling affecting heart rate and salivary cortisol, 948
neuropathology of, 486
in schizophrenia, 81
neuropsychologic findings in, 674
Associative learning in schizophrenia
neurotrophic effects of mood stabilizers, 740
and cerebellar function, 204
and pediatric mania, 458
conditional, 406
perspectives of National Depressive and Manic-Depressive
Astroglia
Association, 442
age affecting glial fibrillary acidic protein immunoreactivity
relation to schizophrenia, 531
in depression, 861
research goals of NIMH, 436
Attention
and response to mecamylamine in Tourette’s syndrome,
time-of-day variations in, 1069
1028
Attention-deficit/hyperactivity disorder
signal transduction in, 518
in adults, 9
subtypes defined, 427-ed
familial association with conduct disorder, 21
treatment advances, 430-ed
and pediatric mania, 458
Body dysmorphic disorder
response inhibition in, 238
family studies of, 287
smooth pursuit eye movements in, 197
Brain
Auditory event-related potentials
N-acetyl-aspartate levels affected by lithium, |
lateralized P3 deficit in schizotypal personality disorder,
activated regions in schizophrenia, 99
702
aldolase A mRNA levels affected by lithium, 58
and onset of adolescent alcohol use, 265
amygdala volumes in pediatric anxiety, 51
P3a in male alcoholics, 276 arousal systems in schizophrenia, 81
Auditory-evoked fields cerebellar function in schizophrenia, 204
anomalous lateralization of M100 in psychosis, 1109 frontal abnormalities in schizophrenia, 110
frontal lobe cytosolic choline levels in adolescent
B lymphoblasts depression, 1053
calcium homeostasis affecting signaling in bipolar disorder, functional connectivity alterations in schizophrenia, 1105
665 genetics and, 1142-ed
Basal ganglia hippocampal volume in geriatric depression, 301
activation in schizophrenia, 99 lateralization
cocaine affecting, 685 auditory M100 in psychosis, 1109